CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.3B
1-Year Est. Return 45.92%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$148M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
516
New
Increased
Reduced
Closed

Top Buys

1
+$7.38M
2
+$5.53M
3
+$4.72M
4
AVGO icon
Broadcom
AVGO
+$3.5M
5
FUTU icon
Futu Holdings
FUTU
+$3.44M

Top Sells

1
+$2.29M
2
+$2.16M
3
+$2.13M
4
ABT icon
Abbott
ABT
+$2.09M
5
TSM icon
TSMC
TSM
+$2.07M

Sector Composition

1 Technology 39.61%
2 Healthcare 20.82%
3 Communication Services 12.95%
4 Consumer Discretionary 11.61%
5 Consumer Staples 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TERN icon
376
Terns Pharmaceuticals
TERN
$3.76B
$115K 0.01%
15,339
-2,202
SIGA icon
377
SIGA Technologies
SIGA
$480M
$115K 0.01%
12,551
-1,798
KROS icon
378
Keros Therapeutics
KROS
$546M
$113K 0.01%
7,119
-1,038
TMDX icon
379
Transmedics
TMDX
$4.58B
$112K 0.01%
+1,000
ARVN icon
380
Arvinas
ARVN
$859M
$110K 0.01%
12,869
-1,791
ERAS icon
381
Erasca
ERAS
$3.25B
$108K 0.01%
49,723
-7,174
SVRA icon
382
Savara
SVRA
$1.1B
$108K 0.01%
30,296
-4,418
TECX
383
Tectonic Therapeutic
TECX
$374M
$108K 0.01%
6,880
+3,130
ANNX icon
384
Annexon
ANNX
$930M
$108K 0.01%
35,261
+13,225
KALV icon
385
KalVista Pharmaceuticals
KALV
$789M
$107K 0.01%
8,824
-1,161
ENTA icon
386
Enanta Pharmaceuticals
ENTA
$374M
$105K 0.01%
8,747
+4,454
PSNL icon
387
Personalis
PSNL
$832M
$101K 0.01%
15,544
-2,196
TNDM icon
388
Tandem Diabetes Care
TNDM
$1.35B
$97.1K 0.01%
+8,000
CRVS icon
389
Corvus Pharmaceuticals
CRVS
$1.73B
$96.3K 0.01%
13,061
-2,427
RZLT icon
390
Rezolute
RZLT
$310M
$94K 0.01%
+10,000
ESPR icon
391
Esperion Therapeutics
ESPR
$810M
$93.7K 0.01%
35,341
-4,467
ZVRA icon
392
Zevra Therapeutics
ZVRA
$507M
$93.6K 0.01%
9,840
-1,142
CMPS
393
Compass Pathways
CMPS
$642M
$92.1K 0.01%
16,076
-2,196
PRTA icon
394
Prothena Corp
PRTA
$474M
$92.1K 0.01%
9,436
-1,375
OMER icon
395
Omeros
OMER
$829M
$89.9K 0.01%
21,929
+10,161
RIGL icon
396
Rigel Pharmaceuticals
RIGL
$633M
$89.1K 0.01%
3,144
-446
MBX
397
MBX Biosciences
MBX
$1.65B
$87.5K 0.01%
+5,000
GLPG icon
398
Galapagos
GLPG
$2.23B
$87K 0.01%
2,511
-465
LXRX icon
399
Lexicon Pharmaceuticals
LXRX
$422M
$86K 0.01%
63,698
-9,245
HCM icon
400
HUTCHMED
HCM
$2.58B
$85.6K 0.01%
5,437
-793
14 15
16
17 18